Author:
Sofronov A. G.,Dobrovolskaya A. E.,Morozova A. Yu.,Gorina E. A.,Kolchev S. A.,Gvozdetckii A. N.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. A. O. Kibitov, A. A. Kurylev, V. M. Brodyanskii, et al., “Combination of dopamine receptor type 2 (DRD2-141C INS/DEL) and protein kinase PKK2 (DRD2/ANKK1 TAQ1A) gene polymorphisms reduces the genetic risk of developing paranoid schizophrenia,” Sotsial. Klin. Psikhiatr., 27, No. 3, 63–72 (2017).
2. Schizophrenia Working Group of the Psychiatric Genomics Consortium, “Biological insights from 108 schizophrenia-associated genetic loci,” Nature, 511, 421–427 (2014), https://doi.org/10.1038/nature13595.
3. M. J. Owen, A. Sawa, and P. B. Mortensen, “Schizophrenia,” Lancet, 388, No. 10039, 86–97 (2016), https://doi.org/10.1016/S0140-6736(15)01121-6.
4. Psychiatric GWAS Consortium Coordinating Committee, S. Cichon, N. Craddock, M. Daly, et al., “Genomewide association studies: history, rationale, and prospects for psychiatric disorders,” Am. J. Psychiatry, 166, No. 5, 540–556 (2009), https://doi.org/10.1176/appi.ajp.2008.08091354.
5. E. C. Johnson, R. Border, W. E. Melroy-Greif, et al., “No evidence that schizophrenia candidate genes are more associated with schizophrenia than noncandidate genes,” Biol. Psychiatry, 82, No. 10, 702–708 (2017), https://doi.org/10.1016/j.biopsych.2017.06.033.